Related references
Note: Only part of the references are listed.Metallodrugs in Medicinal Inorganic Chemistry
Katja Dralle Mjos et al.
CHEMICAL REVIEWS (2014)
Gold(III)-Dithiocarbamato Peptidomimetics in the Forefront of the Targeted Anticancer Therapy: Preclinical Studies against Human Breast Neoplasia
Chiara Nardon et al.
PLOS ONE (2014)
Exploration of the medical periodic table: towards new targets
Nicolas P. E. Barry et al.
CHEMICAL COMMUNICATIONS (2013)
Emerging protein targets for metal-based pharmaceutical agents: An update
Andreia de Almeida et al.
COORDINATION CHEMISTRY REVIEWS (2013)
Ruthenium(II/III)-Based Compounds with Encouraging Antiproliferative Activity against Non-small-Cell Lung Cancer
Eszter M. Nagy et al.
CHEMISTRY-A EUROPEAN JOURNAL (2012)
Coinage Metal Complexes Against Breast Cancer
B. Biersack et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Toward the Selective Delivery of Chemotherapeutics into Tumor Cells by Targeting Peptide Transporters: Tailored Gold-Based Anticancer Peptidomimetics
Morelle Negom Kouodom et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Noble metal-dithiocarbamates precious allies in the fight against cancer
Eszter Márta Nagy et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2012)
Chemotherapeutic induction of mitochondrial oxidative stress activates GSK-3α/β and Bax, leading to permeability transition pore opening and tumor cell death
F. Chiara et al.
CELL DEATH & DISEASE (2012)
Anticancer Activity of Metal Complexes: Involvement of Redox Processes
Ute Jungwirth et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Mitochondrial permeability transition in Ca2+-dependent apoptosis and necrosis
Andrea Rasola et al.
CELL CALCIUM (2011)
Molecular Mechanisms and Proposed Targets for Selected Anticancer Gold Compounds
Angela Casini et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2011)
Promising anticancer mono- and dinuclear ruthenium(III) dithiocarbamato complexes: systematic solution studies
Eszter Marta Nagy et al.
DALTON TRANSACTIONS (2011)
Gold(III)-dithiocarbamato anticancer agents: activity, toxicology and histopathological studies in rodents
Cristina Marzano et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Antitumor activity of gold( III)-dithiocarbamato derivatives on prostate cancer cells and xenografts
Lara Cattaruzza et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Regulation of cancer cell metabolism
Rob A. Cairns et al.
NATURE REVIEWS CANCER (2011)
Cisplatin resistance: Preclinical findings and clinical implications
Beate Koeberle et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2010)
The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes
Arnold J. Levine et al.
SCIENCE (2010)
How mitochondria produce reactive oxygen species
Michael P. Murphy
BIOCHEMICAL JOURNAL (2009)
The Midas touch in cancer chemotherapy: from platinum- to gold-dithiocarbamato complexes
Luca Ronconi et al.
DALTON TRANSACTIONS (2009)
Chemistry, antiproliferative properties, tumor selectivity, and molecular mechanisms of novel gold(III) compounds for cancer treatment: a systematic study
Angela Casini et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2009)
Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1
Hilde Brems et al.
LANCET ONCOLOGY (2009)
Mitochondria in cancer: Not just innocent bystanders
Christian Frezza et al.
SEMINARS IN CANCER BIOLOGY (2009)
Chemical and biological profiles of novel copper(II) complexes containing s-donor ligands for the treatment of cancer
Lorena Giovagnini et al.
INORGANIC CHEMISTRY (2008)
Metal-Ligand Exchange Kinetics in Platinum and Ruthenium Complexes SIGNIFICANCE FOR EFFECTIVENESS AS ANTICANCER DRUGS
Jan Reedijk
PLATINUM METALS REVIEW (2008)
Hexokinase II Detachment from Mitochondria Triggers Apoptosis through the Permeability Transition Pore Independent of Voltage-Dependent Anion Channels
Federica Chiara et al.
PLOS ONE (2008)
Pyrrolidine dithiocarbamate-zinc(II) and -copper(II) complexes induce apoptosis in tumor cells by inhibiting the proteasomal activity
Vesna Milacic et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2008)
Gold(III) - Dithiocarbamato complexes induce cancer cell death triggered by thioredoxin redox system inhibition and activation of ERK pathway
Daniela Saggioro et al.
CHEMISTRY & BIOLOGY (2007)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis
Andrea Rasola et al.
APOPTOSIS (2007)
Hyperactive Ras in developmental disorders and cancer
Suzanne Schubbert et al.
NATURE REVIEWS CANCER (2007)
A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts
Vesna Milacic et al.
CANCER RESEARCH (2006)
Neurofibromin:: a general outlook
A. B. Trovo-Marqui et al.
CLINICAL GENETICS (2006)
The discovery and development of cisplatin
RA Alderden et al.
JOURNAL OF CHEMICAL EDUCATION (2006)
Gold(III) dithiocarbamate derivatives for the treatment of cancer:: Solution chemistry, DNA binding, and hemolytic properties
L Ronconi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Gold dithiocarbamate derivatives as potential antineoplastic agents:: Design, spectroscopic properties, and in vitro antitumor activity
L Ronconi et al.
INORGANIC CHEMISTRY (2005)
Investigation of reduction of Cu(II) complexes in positive-ion mode electrospray mass spectrometry
L Gianelli et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2001)
Gold(III) complexes as potential antitumor agents: Solution chemistry and cytotoxic properties of some selected gold(III) compounds
L Messori et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
